AnnounceMENT

Announcement Details
  • Announcement Title
    Change - Announcement of Cessation
  • Date &Time of Broadcast
    April 1, 2026 7:40 PM
  • Status
    New
  • Announcement Sub Title
    Resignation of Independent Non-Executive Director
  • Announcement Reference
    SG260401OTHR25F0
  • Submitted By (Co./ Ind. Name)
    Weerachai Amornrat-Tana
  • Designation
    Acting Chief Executive Officer and Vice Chairman of the Board
  • Description

    Resignation of Independent Non-Executive Director, Chairman of the Remuneration Committee, a member of the Audit Committee, Nominating Committee, and Investment Committee.

    This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

    The contact person for the Sponsor is Ms Foo Jien Jieng, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg.

Additional Details
  • Name Of Person
    Christopher Tang Kok Kai

    Age
    65

    Is effective date of cessation known?
    Yes

    If yes, please provide the date
    01/04/2026

    Detailed Reason (s) for cessation
    Mr Christopher Tang Kok Kai ("Mr Tang") has resigned as Independent Non-Executive Director of the Company due to increased commitments in his other professional and business engagement. Mr Tang will concurrently relinquish his position as Chairman of the Remuneration Committee, a member of the Audit Committee, Nominating Committee, and Investment Committee. After having interviewed Mr Tang and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that save as disclosed in this announcement, there are no other material reasons for the cessation of Mr Tang as Independent Non-Executive Director of the Company.

    Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
    No

    Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
    No

    Any other relevant information to be provided to shareholders of the listed issuer?
    No

    Date of Appointment to current position
    23/01/2024

    Does the AC have a minimum of 3 members (taking into account this cessation)?
    Yes

    Number of Independent Directors currently resident in Singapore (taking into account this cessation)
    1

    Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
    4

    Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
    Independent Non-Executive Director, Chairman of the Remuneration Committee, a member of Audit Committee, Nominating Committee and Investment Committee

    Role and responsibilities
    Roles and responsibilities of Independent Non-Executive Director, Chairman of the Remuneration Committee, a member of Audit Committee, Nominating Committee and Investment Committee.

    Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
    None

    Shareholding interest in the listed issuer and its subsidiaries?
    No

    Past (for the last 5 years)

    1. FAL Singapore A Pte. Ltd.
    2. FAL Singapore B Pte. Ltd.
    3. FAL Singapore C Pte. Ltd.
    4. FAL Singapore D Pte. Ltd.
    5. FAL Singapore E Pte. Ltd.
    6. FAL Singapore F Pte. Ltd.
    7. Roundtable Ventures Private Limited

    Present

    1. Metro Holdings Limited
    2. FCIH Pte Ltd
    3. Fife Holdings Pte. Ltd.
    4. Fife Capital Singapore Pte. Ltd.
    5. Fife Capital Management Singapore Pte. Limited
    6. Six Plus IP Holdings Pte. Limited
    7. Lionsbridge Development Pte. Ltd.
    8. Grappling Asia Pte Ltd (formerly Glory Rose II     Pte Ltd)
    9. CT Advisory
    10. Ren Ci Hospital

Event Details
Attachments
No items found.